Isolate diffuse thickening of glomerular capillary basement membrane: A renal lesion in prediabetes?

Modern Pathology

Volumn 17, Issue 12, 2004, Pages 1506-1512

  Lai, Fernand Mac Moune ^a   Szeto, Cheuk Chun ^a   Choi, Paul C L ^a   Ho, Kelvin K L ^a   Tang, Nelson L S ^a   Chow, Kai Ming ^a   Li, Philip K T ^a   To, Ka Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetic glomerulosclerosis; Diabetic nephropathy; Glomerular capillary basement membrane; Hyperinsulinemic state; Prediabetes

Indexed keywords

ADULT; AGE; AGED; ARTERIOSCLEROSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; HEMATURIA; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; BASEMENT MEMBRANE; CAPILLARIES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; KIDNEY; KIDNEY GLOMERULUS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; TIME FACTORS;

EID: 10344227151     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800219     Document Type: Article

References (20)

1. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996;27:167-194.
2. Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002;39:713-720.
3. Mac-Moune Lai F, Li PKT, Pang SW, et al. Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol 1993;6:684-690.
4. Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 1996; 39:1638-1645.
5. Bangstad HJ, Osterby R, Dahl-Jorgensen K, et al. Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993;36:523-529.
6. Bangstad HJ, Osterby R, Rudberg S, et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002;45: 253-261.
7. Wong TYH, Choi PCL, Szeto CC, et al. Renal outcome in type 2 diabetic patients with or without coexisting non-diabetic nephropathies. Diabetic Care 2002;25: 900-905.
8. Markowitz GS, Lin J, Valeri AM, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 2002;33:826-835.
9. Hostetter TH. Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med 2001;345: 910-912.
10. Bertani T, Gambara V, Remuzzi G. Structural basis of diabetic nephropathy in microalbuminuric NIDDM patients: a light microscopy study. Diabetologia 1996;39:1625-1628.
11. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2000;23(Suppl 1): S1-S116.
12. Joint National Comittee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
13. Basta-Jovanovic G, Venkataseshan VS, Gil J, et al. Morphometric analysis of glomerular basement membrane (GBM) in thin basement membrane disease (TBMD). Clin Nephrol 1990;33:110-114.
14. Lang S, Stevenson B, Risdon RA. Thin basement membrane nephropathy as a cause of recurrent haematuria in childhood. Histopathology 1990;16: 331-337.
15. Innes A, Furness PN, Cotton RE, et al. Diabetic glomerulosclerosis without diabetes mellitus-two case reports and a review of the literature. Nephrol Dial Transplant 1992;7:642-646.
16. Cusumano AM, Bodkin NL, Hansen BC, et al. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 2002;40:1075-1085.
17. Ritz E, Rychlik I, Locatelli F, et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999;34: 795-808.
18. Lewis EJ, Hunsicker LG, Clarke WR, et al. for Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.
19. Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878.
20. Chan JC, Ng MC, Critchley JA, et al. Diabetes mellitus - a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract 2001;54:S19-S27.